Timing of surgery – After neoadjuvant therapy
Perform surgery within 4-6 weeks after neoadjuvant systemic therapy, allowing for recovery from myelosuppression.
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. The wording is informed by that contained in the Optimal Care Pathway for people with breast cancer (in draft 2020).
Timing of surgery – After neoadjuvant therapy
Perform surgery within 4-6 weeks after neoadjuvant systemic therapy, allowing for recovery from myelosuppression.
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. The wording is informed by that contained in the Optimal Care Pathway for people with breast cancer (in draft 2020).